Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Source
1.2.2. Derivatives
1.2.3. Cultivation
1.2.4. End-use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.2.1. Source outlook
2.2.2. Derivatives outlook
2.2.3. Cultivation outlook
2.2.4. End-use outlook
2.3. Competitive Landscape Snapshot
Chapter 3. Arizona Legal Cannabis Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Case Study Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.4. Regulatory Landscape
Chapter 4. Arizona Legal Cannabis Market Segment Analysis, By Source, 2018 - 2030 (USD Million)
4.1. Definition and Scope
4.2. Source Segment Dashboard
4.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4. Hemp
4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Hemp CBD
4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Industrial Hemp
4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Marijuana
4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2. Flower
4.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Oil and Tinctures
4.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Arizona Legal Cannabis Market Segment Analysis, By Derivatives, 2018 - 2030 (USD Million)
5.1. Definition and Scope
5.2. Derivatives Segment Dashboard
5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4. CBD
5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. THC
5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Arizona Legal Cannabis Market Segment Analysis, By Cultivation, 2018 - 2030 (USD Million)
6.1. Definition and Scope
6.2. Cultivation Segment Dashboard
6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4. Indoor Cultivation
6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Indoor Cultivation
6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Indoor Cultivation
6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Arizona Legal Cannabis Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)
7.1. Definition and Scope
7.2. End Use Segment Dashboard
7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4. Industrial Use
7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Medical Use
7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.2. Chronic Pain
7.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.3. Depression and Anxiety
7.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.4. Arthritis
7.5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.5. Post Traumatic Stress Disorder (PTSD)
7.5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.6. Cancer
7.5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.7. Migraines
7.5.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.8. Epilepsy
7.5.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.9. Alzheimer’s
7.5.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.10. Multiple Sclerosis
7.5.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.11. Amyotrophic Lateral Sclerosis
7.5.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.12. Tourette’s
7.5.12.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.13. Diabetes
7.5.13.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.14. Parkinson's
7.5.14.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.15. Glaucoma
7.5.15.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.16. Others
7.5.16.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Recreational Use
7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company Categorization
8.3. Company Market Position Analysis
8.4. Company Profiles
8.4.1. Harvest Health & Recreation Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Service Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Curaleaf Holdings, Inc.
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Service Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Copperstate Farms
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Service Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Acreage Holdings
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Service Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Cresco Labs
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Service Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Vext Science, Inc.
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Service Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Trulieve
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Service Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Presidential RX
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Service Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. The Mint Dispensary
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Service Benchmarking
8.4.9.4. Strategic Initiatives
List of Tables
Table 1 LIST OF SECONDARY SOURCES
Table 2 LIST OF ABBREVIATIONS
Table 3 ARIZONA LEGAL CANNABIS MARKET, BY SOURCE, 2018 - 2030 (USD Million)
Table 4 ARIZONA LEGAL CANNABIS MARKET, BY DERIVATIVES, 2018 - 2030 (USD Million)
Table 5 ARIZONA LEGAL CANNABIS MARKET, BY CULTIVATION, 2018 - 2030 (USD Million)
Table 6 ARIZONA LEGAL CANNABIS MARKET, BY END USE, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Value-chain-based sizing & forecasting
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market research approaches
Fig. 7 Market formulation & validation
Fig. 8 Arizona cannabis market: market outlook
Fig. 9 Arizona cannabis competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook.
Fig. 12 Industry value chain analysis
Fig. 13 Arizona legal cannabis market driver impact
Fig. 14 Arizona legal cannabis market restraint impact
Fig. 15 Arizona legal cannabis market strategic initiatives analysis
Fig. 16 Arizona legal cannabis market: Source movement analysis
Fig. 17 Arizona legal cannabis market: Source outlook and key takeaways
Fig. 18 Hemp market estimates and forecasts, 2018 - 2030
Fig. 19 Hemp CBD market estimates and forecasts, 2018 - 2030
Fig. 20 Industrial Hemp market estimates and forecasts, 2018 - 2030
Fig. 21 Marijuana market estimates and forecasts, 2018 - 2030
Fig. 22 Flower market estimates and forecasts, 2018 - 2030
Fig. 23 Oil and Tinctures market estimates and forecasts, 2018 - 2030
Fig. 24 Arizona legal cannabis market: Derivatives movement analysis
Fig. 25 Arizona legal cannabis market: Derivatives outlook and key takeaways
Fig. 26 CBD market estimates and forecasts, 2018 - 2030
Fig. 27 THC market estimates and forecasts, 2018 - 2030
Fig. 28 Others market estimates and forecasts, 2018 - 2030
Fig. 29 Arizona legal cannabis market: Cultivation movement analysis
Fig. 30 Arizona legal cannabis market: Cultivation outlook and key takeaways
Fig. 31 Indoor Cultivation market estimates and forecasts, 2018 - 2030
Fig. 32 Greenhouse Cultivation market estimates and forecasts, 2018 - 2030
Fig. 33 Outdoor Cultivation market estimates and forecasts, 2018 - 2030
Fig. 34 Arizona legal cannabis market: End-use movement analysis
Fig. 35 Arizona legal cannabis market: End-use outlook and key takeaways
Fig. 36 Industrial Use market estimates and forecasts, 2018 - 2030
Fig. 37 Medical Use market estimates and forecasts, 2018 - 2030
Fig. 38 Chronic Pain market estimates and forecasts, 2018 - 2030
Fig. 39 Depression and Anxiety market estimates and forecasts, 2018 - 2030
Fig. 40 Arthritis market estimates and forecasts, 2018 - 2030
Fig. 41 Post Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018 - 2030
Fig. 42 Cancer market estimates and forecasts, 2018 - 2030
Fig. 43 Migraines market estimates and forecasts, 2018 - 2030
Fig. 44 Epilepsy market estimates and forecasts, 2018 - 2030
Fig. 45 Alzheimer’s market estimates and forecasts, 2018 - 2030
Fig. 46 Multiple Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 47 AIDS market estimates and forecasts, 2018 - 2030
Fig. 48 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 49 Tourette’s market estimates and forecasts, 2018 - 2030
Fig. 50 Diabetes market estimates and forecasts, 2018 - 2030
Fig. 51 Parkinson's market estimates and forecasts, 2018 - 2030
Fig. 52 Glaucoma market estimates and forecasts, 2018 - 2030
Fig. 53 Others market estimates and forecasts, 2018 - 2030
Fig. 54 Recreational Use market estimates and forecasts, 2018 - 2030
Fig. 55 Key company categorization
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.
